Mechanisms of loss of lean body mass in patients on chronic dialysis

被引:28
作者
Dinarello, CA [1 ]
Roubenoff, RA [1 ]
机构
[1] TUFTS UNIV,DEPT MED,BOSTON,MA 02111
关键词
malnutrition; cytokines; IL-1; tumor necrosis factor; IL-6; inflammation;
D O I
10.1159/000170291
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients on chronic dialysis treatment often have reduced lean body mass. Certain aspects of bio-incompatibility in dialysis can be viewed as leading to a chronic inflammatory state, In most chronic inflammatory diseases, loss of mean body mass is independent of reduced caloric intake, However, reduced caloric intake accounts for most of the weight loss in these patients and also dialysis patients, Refeeding is associated with increased fat deposition more than restoration of muscle mass, In addition to reduced caloric intake, patients with rheumatoid arthritis, a classic example of a chronic inflammatory disease, have an elevated resting energy expenditure associated with decreased lean body mass. Elevated cellular tumor necrosis factor (TNF) and IL-1 beta production can be demonstrated in these patients. However, in many dialysis patients, increased cytokine production can be 'normal' or reduced. This takes place as the level of malnutrition increases. Thus, cytokines such as IL-1 and TNF play a decreasing role in the pathogenesis of loss of body mass as malnutrition increases and curtails the synthesis of cytokines, Similar to patients with AIDS, progressive disease in patients on chronic dialysis may exhibit subclinical malnutrition which leads to decreased cytokine production, Reduction in cytokine production can be viewed as a protective mechanism.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 27 条
[21]   CILIARY NEUROTROPHIC FACTOR IS AN ENDOGENOUS PYROGEN [J].
SHAPIRO, L ;
ZHANG, XX ;
RUPP, RG ;
WOLFF, SM ;
DINARELLO, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) :8614-8618
[22]   THE MOUSE-HUMAN CHIMERIC MONOCLONAL-ANTIBODY CA2 NEUTRALIZES TNF IN-VITRO AND PROTECTS TRANSGENIC MICE FROM CACHEXIA AND TNF LETHALITY IN-VIVO [J].
SIEGEL, SA ;
SHEALY, DJ ;
NAKADA, MT ;
LE, JM ;
WOLFE, DS ;
PROBERT, L ;
KOLLIAS, G ;
GHRAYEB, J ;
VILCEK, J ;
DADDONA, PE .
CYTOKINE, 1995, 7 (01) :15-25
[23]   THE EFFECTS OF TREATMENT WITH INTERLEUKIN-1-ALPHA ON PLATELET RECOVERY AFTER HIGH-DOSE CARBOPLATIN [J].
SMITH, JW ;
LONGO, DL ;
ALVORD, WG ;
JANIK, JE ;
SHARFMAN, WH ;
GAUSE, BL ;
CURTI, BD ;
CREEKMORE, SP ;
HOLMLUND, JT ;
FENTON, RG ;
SZNOL, M ;
MILLER, LL ;
SHIMIZU, M ;
OPPENHEIM, JJ ;
FIEM, SJ ;
HURSEY, JC ;
POWERS, GC ;
URBA, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (11) :756-761
[24]   THE TOXIC AND HEMATOLOGIC EFFECTS OF INTERLEUKIN-1-ALPHA ADMINISTERED IN A PHASE-I TRIAL TO PATIENTS WITH ADVANCED MALIGNANCIES [J].
SMITH, JW ;
URBA, WJ ;
CURTI, BD ;
ELWOOD, LJ ;
STEIS, RG ;
JANIK, JE ;
SHARFMAN, WH ;
MILLER, LL ;
FENTON, RG ;
CONLON, KC ;
SZNOL, M ;
CREEKMORE, SP ;
WELLS, NF ;
RUSCETTI, FW ;
KELLER, JR ;
HESTDAL, K ;
SHIMIZU, M ;
ROSSIO, J ;
ALVORD, WG ;
OPPENHEIM, JJ ;
LONGO, DL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) :1141-1152
[25]   INTERLEUKIN-1 POTENTIATES GLUCOSE STIMULATED INSULIN RELEASE IN THE ISOLATED PERFUSED PANCREAS [J].
WOGENSEN, LD ;
MANDRUPPOULSEN, T ;
MARKHOLST, H ;
MOLVIG, J ;
LERNMARK, A ;
HOLST, JJ ;
DINARELLO, CA ;
NERUP, J .
ACTA ENDOCRINOLOGICA, 1988, 117 (03) :302-306
[26]   MUSCLE PROTEIN BREAKDOWN DURING ENDOTOXEMIA IN RATS AND AFTER TREATMENT WITH INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) [J].
ZAMIR, O ;
HASSELGREN, PO ;
OBRIEN, W ;
THOMPSON, RC ;
FISCHER, JE ;
WILMORE, DW ;
LOWRY, ST ;
PRUITT, BA .
ANNALS OF SURGERY, 1992, 216 (03) :381-387
[27]  
ZHENG H, 1995, IN PRESS IMMUNITY